The short version of Metabolite fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2025-07-29 and is reviewed periodically as new material appears.
Products sold as cardarine have been found to contain incorrect compounds, variable amounts, or no active ingredient at all. Independent testing is required to verify identity and purity. Common analytical approaches include high-performance liquid chromatography, mass spectrometry, and nuclear magnetic resonance for structural confirmation. These methods can distinguish GW501516 from related PPAR agonists and from unrelated steroids. For regulators and researchers, such verification is central to interpreting both biological results and adverse event reports.
Cardarine is prohibited in competitive sport under the World Anti-Doping Agency code, where it is classified as a metabolic modulator. It is not approved as a prescription medicine in the United States, European Union, or other major markets. Regulatory action has focused on its presence in sports and in products marketed as research chemicals. Because it has no accepted medical indication, supply is often unregulated. This status creates legal and safety uncertainties for anyone who encounters the substance.
Anti-doping laboratories detect GW501516 and its metabolites using liquid chromatography-tandem mass spectrometry. Urine is the most common matrix, though blood and dried blood spots may also be used in some programs. Detection depends on factors such as dose, timing, metabolism, and the sensitivity of the assay. Published methods describe limits of detection in the low nanogram per milliliter range for related compounds. Exact detection windows are not fixed for all situations and remain an area of ongoing study.
Laboratory detection of cardarine typically involves sample preparation followed by chromatographic separation and mass spectrometric identification. Urine is the most common matrix for anti-doping tests, though blood and hair have also been explored. Methods can target the parent compound or its metabolites, depending on the expected window of detection. Reference standards are required for accurate quantification. Matrix effects and dilution can influence results, so laboratories use internal standards and validation protocols. The exact detection window varies with dose, route, and individual metabolism.
A common misconception is that cardarine has been proven safe for human use. In reality, human clinical data are limited, and long-term animal studies have raised concerns about cancer. Another misconception is that it is a supplement or vitamin-like compound. It is a synthetic research chemical with no approved medical indication. Scientific discussion often focuses on its mechanism and detection rather than therapeutic use. Regulatory and anti-doping literature treats it primarily as a prohibited substance.
| Property | Value | Notes |
|---|---|---|
| Regulatory status | Prohibited in sport | Listed by WADA as a metabolic modulator. |
| Approved medical use | None in major jurisdictions | Not a registered drug. |
| Common test matrix | Urine | Most anti-doping samples use urine. |
| Typical detection method | LC-MS/MS | Detects parent compound and metabolites. |
| Reference standard storage | -20 °C, desiccated | Typical for analytical standards. |
Legal status varies by country. In some places, cardarine is controlled under medicines or psychoactive substances laws; in others, it may be sold with minimal oversight as a research chemical. Customs agencies have intercepted shipments, and several national health agencies have issued warnings about products marketed for bodybuilding or performance enhancement. The lack of a standardized pharmaceutical supply means identity, purity, and contamination levels can differ widely between samples. These factors make cardarine a regulatory and public health concern rather than a conventional prescription drug.
Cardarine is a common name for GW501516, a synthetic compound first described in the 1990s as a selective agonist of the peroxisome proliferator-activated receptor delta. It was studied in preclinical models for metabolic and cardiovascular conditions, but it has not been approved as a medicine in the United States, Europe, or other major jurisdictions. Retail products labeled as cardarine are generally research chemicals or supplements, not pharmaceutical formulations. Because human safety and efficacy data remain limited, regulatory agencies treat it as an unapproved substance rather than a therapeutic product.
Clinical development stopped after rodent studies showed tumors at multiple sites. Whether those findings predict human cancer risk remains an open question, but they led sponsors to discontinue programs. Human safety data are limited to small, short-term studies that were not designed to assess cancer risk. Reported effects in those studies included changes in blood lipids, but the evidence is insufficient for medical use. Long-term consequences of nonmedical use are not well characterized. Questions about dose, duration, and individual susceptibility remain unresolved.
Cardarine is a common name for GW501516, an investigational compound developed in the 1990s for metabolic conditions. It acts as an agonist at peroxisome proliferator-activated receptor delta, a nuclear receptor involved in lipid and energy metabolism. The compound is frequently mislabeled as a selective androgen receptor modulator, or SARM, but its molecular target is different. GW501516 reached early clinical testing before development was discontinued. It has no approved therapeutic use in any country. The name cardarine is not a formal international nonproprietary name.
=== Other possible solutions === Significant strides may be made relatively quickly if the focus shifts towards surgical subspecialties and their involvement in generated medical waste. Surgical specialties in particular have focused on infection control and thus have implemented single-use operative tools in their practices. One example of this can be seen within the practice of gastroenterology, where each endoscopy alone in the U.S. generates approximately 2.1 kg of disposable waste, of which 64% of the waste ended up in landfills. Thankfully, it appears that surgeons across the U.S. have agreed that their practice generates a high amount of waste and that a change needs to be implemented. A multi-center survey of 219 U.S. surgeons showed that 90% of them agreed strongly that waste of sterile surgical items is an issue and moreover, 95% of them agreed to a willingness to change their operating room workflow to reduce waste. Another focus that proves to be effective is reform around the policies that surround "red bag waste." Separation of medical waste is typically done via these bags and a narrative review out of U.S. operating rooms found that 90% of red bag waste, or the items found in the red waste bags, did not actually meet the criteria for pathologic or infectious waste. Initiative from corporations and hospitals is essential to creating a healthier environment, however, there are various methods in which involves action from the general population and would contribute to a clean air environment.
== Further reading == Habibi, N; Kamaly, N; Memic, A; Shafiee, H (2016). "Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery". Nano Today. 11 (1): 41–60. doi:10.1016/j.nantod.2016.02.004. PMC 4834907. PMID 27103939.
The chief characteristic of proteins that allows their diverse set of functions is their ability to bind other molecules specifically and tightly. The region of the protein responsible for binding another molecule is known as the binding site and is often a depression or "pocket" on the molecular surface. This binding ability is mediated by the tertiary structure of the protein, which defines the binding site pocket, and by the chemical properties of the surrounding amino acids' side chains. Protein binding can be extraordinarily tight and specific; for example, the ribonuclease inhibitor protein binds to human angiogenin with a sub-femtomolar dissociation constant (< 10−15 M) but does not bind at all to its amphibian homolog onconase (> 1 M). Extremely minor chemical changes such as the addition of a single methyl group to a binding partner can sometimes suffice to nearly eliminate binding; for example, the aminoacyl tRNA synthetase specific to the amino acid valine discriminates against the very similar side chain of the amino acid isoleucine. Proteins can bind to other proteins as well as to small-molecule substrates. When proteins bind specifically to other copies of the same molecule, they can oligomerize to form fibrils; this process occurs often in structural proteins that consist of globular monomers that self-associate to form rigid fibers.
Infants can be infected during passage through the birth canal; nevertheless, newborns who acquire GBS through this route may only become colonized, and these colonized infants typically do not develop EOD. Roughly 50% of newborns to GBS colonized mothers are also GBS colonized, and (without prevention measures) 1–2% of these newborns will develop EOD. In the past, the incidence of EOD ranged from 0.7 to 3.7 per thousand live births in the US and from 0.2 to 3.25 per thousand in Europe.Multistate surveillance 2006-2015 shows a decline in EOD from 0.37 to 0.23 per 1000 live births in the US, but LOD remains steady at 0.31 per 1000 live births. In 2021 had been estimated a total of 1970 deaths (0.59/100,000 population) in the US were estimated to be caused by GBS neonatal infections. It was estimated that 226 infants (49 per 100,000) in the United States had a clinically significant GBS infection, and that approximately 11 (2.4%) of those cases resulted in death. The widespread use of intrapartum antibiotic prophylaxis (IAP) has resulted in a decline in the incidence of early neonatal GBS infection in the United States of more than 85%, from 1.8‰ of cases in live births in the 1990s to 0.23‰ in 2015, and to 0.18‰ in 2023.
Sources: en.wikipedia.org
22 April 2016: Phua Han Chuan Jeffery, a Singaporean and chronic ketamine abuser who was arrested on 20 January 2010 for trafficking more than 100g of heroin into Singapore at Woodlands Checkpoint. He was found guilty and sentenced to death in September 2011. Phua, who lost his three previous appeals against the sentence between July 2012 to September 2015, was granted a re-trial two years and eight months after the government implemented new changes to the death penalty laws (in 2013). He was diagnosed to be suffering from persistent depressive disorder, and the condition, coupled with his chronic ketamine addiction, was argued by Phua's lawyers as sufficient to impair his mental responsibility at the time of the crime. The High Court accepted the defence's arguments and thus re-sentenced Phua, then 30 years old, to life-long incarceration on 22 April 2016, with his sentence backdated to the date of his remand. 27 April 2022: Nagaenthran K Dharmalingam, a Malaysian convicted of trafficking heroin in 2009 and sentenced to death in 2010. After changes to the law took effect in 2013, he applied for re-sentencing but had his application rejected. His appeals to the Court of Appeal were dismissed in 2019. In May 2019 he planned to appeal to the President of Singapore for clemency, but he lost his plea and his execution date was scheduled on 10 November 2021. However, Nagaenthran contracted COVID-19 while in prison and he also made an appeal, hence his execution was postponed and the appeal itself was also postponed twice.
Anti-inflammatory: Calotropis extracts have been used traditionally to alleviate inflammation. The latex of the plant contains compounds that possess anti-inflammatory properties. Traditional uses of Calotropis include treating skin conditions such as eczema, psoriasis, and other inflammatory skin disorders. Its anti-inflammatory and wound-healing properties may contribute to these potential benefits. Antimicrobial: Certain parts of Calotropis, especially the latex, have shown antimicrobial activity against various bacterial and fungal pathogens. This property has been utilized in traditional medicine to treat skin infections and wounds. The antimicrobial activity of Calotropis plants has been attributed to the presence of various bioactive compounds such as alkaloids, flavonoids, and terpenoids. A study found that the latex of Calotropis procera has significant antimicrobial activity against various bacterial and fungal pathogens, including Staphylococcus aureus, Escherichia coli, and Candida albicans Wound Healing: The latex of Calotropis has been used topically to promote wound healing. It is believed to help in the formation of granulation tissue and facilitate the healing process. Analgesic (Pain Relief): Some traditional practices involve using Calotropis preparations to relieve pain and discomfort. Gastrointestinal Disorders: Some traditional medicinal practices use Calotropis to alleviate gastrointestinal issues such as constipation and dysentery. However, its laxative effects are strong and can lead to adverse effects.
=== Creative food design === Food presentation and food appearance customization for individuals is a big trend in the food industry. So far food customization and creative designs have required hand-made skills, which results in low production rate and high cost. 3D food printing can overcome this problem by providing the necessary tools for creative food design even for home users. 3D food printing has enabled some intricate designs which cannot be accomplished with traditional food manufacturing. Brand logos, text, signatures, pictures can now be printed on some food products like pastries and coffee. Complex geometric shapes have also been printed, mainly using sugar. With 3D printing, chefs can now turn their visual inspirations into signature culinary creations. Another benefit is being able to print nutritious meals in shapes that appeal to children.
== Etymology == The first written use of the term "vegetarian" originated in the early 19th century, when authors referred to a vegetable regimen diet. Historically, 'vegetable' could be used to refer to any type of edible vegetation. Modern dictionaries explain its origin as a compound of vegetable (adjective) and the suffix -arian (in the sense of agrarian). The term was popularized with the foundation of the Vegetarian Society in Manchester in 1847, although it has been in use since around 1839 to refer to what was previously called a vegetable regimen or diet. It was used in writing first attributed to actress, writer and abolitionist Fanny Kemble, in her Journal of a Residence on a Georgian plantation in 1838–1839. The earliest occurrences of the term seem to be related to Alcott House—a school on the north side of Ham Common, London—which was opened in July 1838 by James Pierrepont Greaves. From 1841, it was known as A Concordium, or Industry Harmony College, and the institution then began to publish its own pamphlet, The Healthian. It provides some of the earliest appearances of the term "vegetarian".
Vkusno i Tochka (Russian: Вкусно – и точка, IPA: [ˈfkusnə ɪ ˈtotɕkə], lit. 'Tasty, period') is a Russian fast food chain based mostly in former McDonald's restaurants, with a menu that largely consists of rebranded McDonald's items. McDonald's closed their Russian stores in response to the 2022 Russian invasion of Ukraine; Vkusno i Tochka restaurants mostly occupy former McDonald's restaurants that were sold to business magnate and entrepreneur Alexander Govor, who was a company licensee in Siberia. The first restaurants in Russia were opened on 12 June 2022; since then, Vkusno i Tochka restaurants have also opened in Belarus and Kazakhstan, albeit under different names, also based mostly in former McDonald's restaurants in those two countries.
Sources: en.wikipedia.org
Legal status varies by country, but cardarine is not approved as a medicine in major jurisdictions. It is often sold as a research chemical, a category that may not be lawful for human use. Buyers should check local laws and product labels carefully.
Anti-doping laboratories use LC-MS/MS to detect GW501516 and its metabolites, usually in urine. The method can identify the parent compound at low concentrations. Detection windows vary with dose and individual factors.
No, cardarine has no approved medical uses in major jurisdictions. Early research explored metabolic conditions, but those programs were discontinued. It is not a registered treatment for any disease.
Yes, WADA prohibits cardarine as a PPARδ agonist. It appears on the prohibited list and can be detected in urine or blood. Athletes using it risk sanctions.